
Moderna used its 2026 Analyst Day to outline an oncology-driven growth strategy anchored by intismeran and other cancer antigen therapies.
AI agents are moving into healthcare faster than most organizations can supervise them. In this conversation, Amy Brown, CEO of Authenticx, argues that every AI agent will eventually fail—and that the real differentiator isn't which company deploys AI first, but which one can see, catch, and correct what its AI is doing before a patient or member is harmed.
Learning Objectives:




